Navigation Links
Anti-angiogenesis treatment improves hearing in some NF2 patients
Date:7/8/2009

Treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2). In a paper to appear in the July 23 New England Journal of Medicine, which is receiving early online release, researchers from Massachusetts General Hospital (MGH) report that bevacizumab treatment successfully shrank characteristic tumors in a small group of NF2 patients, the first reported successful NF2 treatment not involving surgery or radiation.

"This kind of treatment response is unprecedented," says Scott Plotkin, MD, PhD, of the Pappas Center for Neuro-Oncology in the MGH Cancer Center, lead author of the NEJM paper. "Our study is the first to provide evidence that a drug can shrink vestibular schwannomas benign tumors on the balance and hearing nerves and the first to show that patients' hearing can be improved."

NF2 is an inherited genetic disorder in which benign tumors develop throughout the nervous system. Vestibular schwannomas are the most common NF2-associated tumors, and although they grow slowly, they usually cause patients to lose all or most of their hearing by young adulthood or middle age. The tumors can be removed surgically or treated with radiation, but in patients with vestibular schwannomas on both sides, which is typical in NF2, such treatment usually leads to complete hearing loss. Growing vestibular schwannomas can also press on the brainstem, leading to headaches, difficulty swallowing and other serious neurologic symptoms.

Since vestibular schwannomas are benign tumors, it was believed that they did not stimulate formation of new blood vessels as malignant tumors do. However, when the researchers studied tissue samples from NF2-related schwannomas, sporadic tumors not caused by NF2 and normal spinal nerves, they found evidence of excess blood vessel development and increased expression of angiogenesis-related molecules in both NF2-associa
'/>"/>

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related medicine news :

1. Drug Shows Promise in Nervous-System Tumor Treatment
2. Evidence-based information about complementary and alternative medicine treatments now available
3. Researchers identify potential patient safety risks among methadone maintenance treatment patients
4. Global Fund Increases AIDS, Tuberculosis and Malaria Prevention and Treatment Measures by 30-50% Over One Year
5. For Treatment of Dyslipidemia, Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials
6. National Survey: Americans Fear Paying for Cancer Treatment As Much As Dying of the Disease
7. Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment
8. U.S. Food and Drug Administration and Xanodyne Agree on a Plan to Keep Propoxyphene-Containing Products Available as Treatment Options for the Management of Mild to Moderate Pain
9. Rice University teams award-winning device could benefit treatment of hand injuries
10. June 2009 Mayo Clinic Health Letter Highlights Probiotics, Carotid Artery and Breast Cancer Treatments
11. New strategies to improve treatment and ultimately prevent heart failure in children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Octo Consulting Group, an ... consulting solutions to the Federal marketplace, has named ... In the newly created role, Denny will be ... the firm’s business development function to include business ... and leading strategies to achieve the firm’s strategic ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay ... steroid therapy for patients having severe bouts of chronic ... Five days of glucocorticoid treatment with prednisone to treat ... days, but with fewer chances for adverse side effects, ... shorter period of treatment was not less effective than ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... of sleep apnea in children, and while removing them ... kids, it did help them with sleep, behavior and ... apnea is a condition that causes abnormal pauses in ... in sleep with the surgery, and those improvements were ...
(Date:5/21/2013)... at high risk for developing lung cancer shows that ... helping clinicians spot tiny lung nodules which, in a ... of the disease. LDCT uses less than a quarter ... Results of the study will be presented at the ... leading cause of cancer-related death and has a poor ...
(Date:5/21/2013)... Mexican young adults may have a genetic predisposition for ... a study at the Universidad Autnoma de San Luis ... from both parents were already 15 pounds heavier and ... hadn,t. They also had slightly higher fasting glucose levels," ... food science and human nutrition. , In the study, ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 2Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 3Health News:Low radiation scans help identify cancer in earliest stages 2Health News:Low radiation scans help identify cancer in earliest stages 3Health News:Genetic risk for obesity found in many Mexican young adults 2
... Treatment of heart patients no better after performance data released ... -- One might assume that public report cards ranking their ... study finds that isn,t the case. , Researchers found ... better job of treating heart patients after report cards were ...
... , ... November 16, 2009. , ... November 18, 2009 -- Ziosoft®, Inc. http://www.ziosoftinc.com -- a leader in advanced visualization ... vice president, sales and marketing, effective November 16., , , , ,Most recently, Royea served ...
... ... and Security Suite to deliver end-to-end endpoint management solution capabilities on a single ... ... 2009 -- Lumension , a global leader in endpoint management and security, ...
... Physicians for Social Responsibility today released a groundbreaking ... look at the devastating impacts of coal on the human body. ... organ systems of the human body, the report concludes that coal ... the U.S. and is responsible for increasing the incidence of major ...
... , MINEOLA, N.Y., Nov. 18 The United ... for when a woman should be getting a mammography. ... has made an official statement regarding her research and ... , Yesterday, The United States Preventive Services Task ...
... , BRIGHTON, Mass., Nov. 18 Sleep Health Centers ... US, is proud to announce the formation of SleepPartners ( ... accredited sleep centers with board-certified sleep specialists and a focus ... sleep programs combined with their geographic reach extends high quality ...
Cached Medicine News:Health News:Study Shows Hospital Report Cards Unlikely to Spur Improvement 2Health News:Ziosoft Announces the Appointment of Rob Royea, Vice President, Sales and Marketing 2Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 2Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 3Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 4Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 5Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 6Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 7Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 8Health News:Coal Pollution Damages Human Health at Every Stage of Coal Life Cycle, Reports Physicians for Social Responsibility 2Health News:Coal Pollution Damages Human Health at Every Stage of Coal Life Cycle, Reports Physicians for Social Responsibility 3Health News:Coal Pollution Damages Human Health at Every Stage of Coal Life Cycle, Reports Physicians for Social Responsibility 4Health News:Coal Pollution Damages Human Health at Every Stage of Coal Life Cycle, Reports Physicians for Social Responsibility 5Health News:Maurer Foundation for Breast Health Education Statement on USPSTF Guidelines for Mammography 2Health News:Sleep HealthCenters Launches SleepPartners(TM) Network 2
(Date:5/21/2013)... TARRYTOWN, N.Y. , May 21, 2013 /PRNewswire/ ... Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the ... positive Phase 2a study results of dupilumab (SAR231893/REGN668) in ... monoclonal antibody targeting the alpha subunit of the interleukin ... IL-4 and IL-13, drivers of Th2 (Type 2 helper ...
(Date:5/21/2013)... 2013 Abaxis, Inc. (NasdaqGS: ABAX), a medical ... that Martin Mulroy , chief commercial ... & Veterinary Conference on Wednesday, May 29, 2013 at ... Le Parker Meridien Hotel in New York ... Abaxis develops, manufactures, markets and sells portable blood analysis ...
(Date:5/21/2013)... YORK , May 21, 2013 /PRNewswire/ ... research report is available in its catalogue: ... Regulatory and Reimbursement Scenario for Medical Devices ... http://www.reportlinker.com/p01188015/Changing-Regulatory-and-Reimbursement-Scenario-for-Medical-Devices-in-the-US-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging   Changing ... in the US Market   ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4
... 9, 2011 /PRNewswire-Asia/ -- Vaccines made in China ... agencies to developing countries, after recognition from the ... and Drug Administration (SFDA) has complied with international ... regulatory system is a precondition that could lead ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ... Court for the District of Massachusetts has granted ... Inc. for a temporary restraining order (TRO) preventing ... selling Amphastar,s Enoxaparin Sodium Injection product, a generic ...
Cached Medicine Technology:VacChina 2011 International Conference Meets in Shanghai This November 2Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R) 2Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R) 3
... An Antiseptic Antibacterial that does ... than 30 seconds, destroys over ... used for cleansing of minor ... for disinfection of personal utensils ...
... Bactericide, Microbicide for professional degerming, pre-op ... skin disinfectants combining quaternary and substituted ... blend of emollients and surfactants. Unprecedented ... organisms tested in 30 seconds. Techni-Care ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... solution is for broad-spectrum germicidal ... is labeled for single use ... contamination. The controlled spray mist ... the final step of the ...
Medicine Products: